Recent advances in the inhibition of the il-4 cytokine pathway for the treatment of allergen-induced asthma
Massey, Oliver and Suphioglu, Cenk 2021, Recent advances in the inhibition of the il-4 cytokine pathway for the treatment of allergen-induced asthma, International Journal of Molecular Sciences, vol. 22, no. 24, pp. 1-10, doi: 10.3390/ijms222413655.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Recent advances in the inhibition of the il-4 cytokine pathway for the treatment of allergen-induced asthma
The IL-4 and IL-13 cytokine pathways play integral roles in stimulating IgE inflammation, with the IL-4 cytokine being a major cytokine in the etiology of thunderstorm asthma, atopic dermatitis, and allergic rhinitis. The increasing prevalence of thunderstorm asthma in the younger population and the lessening efficacy of corticosteroids and other anti-inflammatories has created a need for more effective pharmaceuticals. This review summarizes the IL-4 and IL-13 pathways while highlighting and discussing the current pathway inhibitors aimed at treating thunderstorm asthma and atopic dermatitis, as well as the potential efficacy of peptide therapeutics in this field.
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.